Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells
ConclusionsThese findings suggest that glycopyrronium, formoterol, and a combination of glycopyrronium, formoterol, and budesonide inhibit HCoV-229E replication partly by inhibiting receptor expression and/or endosomal function and that these drugs modulate infection-induced inflammation in the airway.
Source: Respiratory Investigation - Category: Respiratory Medicine Source Type: research
More News: Asthma | Chronic Obstructive Pulmonary | Common Cold | Coronavirus | Corticosteroid Therapy | Respiratory Medicine | Symbicort